메뉴 건너뛰기




Volumn 24, Issue 3, 2008, Pages 659-670

Serum lipid profiles and their relationship to cardiovascular disease in the elderly: The PREV-ICTUS study

Author keywords

Cardiovascular disease; Dyslipidaemia; Elderly; High density lipoprotein cholesterol; Low density lipoprotein cholesterol; Population based study; Triglycerides

Indexed keywords

ANTILIPEMIC AGENT; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

EID: 41149156980     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079908X273372     Document Type: Article
Times cited : (28)

References (46)
  • 1
    • 0022505110 scopus 로고
    • Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFe (Multiple Risk Factor Intervention Trial)
    • Kannel WB, Neaton JD, Wentworth D, et al. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFe (Multiple Risk Factor Intervention Trial). Am Heart J 1986;112:825-36
    • (1986) Am Heart J , vol.112 , pp. 825-836
    • Kannel, W.B.1    Neaton, J.D.2    Wentworth, D.3
  • 2
    • 0023025526 scopus 로고
    • Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT)
    • Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986;256:2823-8
    • (1986) JAMA , vol.256 , pp. 2823-2828
    • Stamler, J.1    Wentworth, D.2    Neaton, J.D.3
  • 3
    • 0023880042 scopus 로고
    • High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction: The Framingham Study
    • Abbott RD, Wilson PW, Kannel WB, Castelli WP. High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction: the Framingham Study. Arteriosclerosis 1988;8:207-11
    • (1988) Arteriosclerosis , vol.8 , pp. 207-211
    • Abbott, R.D.1    Wilson, P.W.2    Kannel, W.B.3    Castelli, W.P.4
  • 4
    • 0023029454 scopus 로고
    • Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham Study
    • Castelli WP, Garrison RJ, Wilson PW, et al. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA 1986;256:2835-8
    • (1986) JAMA , vol.256 , pp. 2835-2838
    • Castelli, W.P.1    Garrison, R.J.2    Wilson, P.W.3
  • 5
    • 0028174806 scopus 로고
    • Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study
    • Sharrett AR, Patsch W, Sorlie PD, et al. Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 1994;14:1098-104
    • (1994) Arterioscler Thromb , vol.14 , pp. 1098-1104
    • Sharrett, A.R.1    Patsch, W.2    Sorlie, P.D.3
  • 6
    • 0027987849 scopus 로고
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9
    • (1994) Lancet , vol.344 , pp. 1383-1389
  • 7
    • 0342981862 scopus 로고    scopus 로고
    • The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events Trial investigators
    • Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996;335:1001-9
    • (1996) N Engl J Med , vol.335 , pp. 1001-1009
    • Sacks, F.M.1    Pfeffer, M.A.2    Moye, L.A.3
  • 8
    • 0028883828 scopus 로고
    • Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group
    • Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group. N Engl J Med 1995;333:1301-7
    • (1995) N Engl J Med , vol.333 , pp. 1301-1307
    • Shepherd, J.1    Cobbe, S.M.2    Ford, I.3
  • 9
    • 0032572086 scopus 로고    scopus 로고
    • Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS (Air Force/Texas Coronary Atherosclerosis Prevention Study)
    • Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS (Air Force/Texas Coronary Atherosclerosis Prevention Study). JAMA 1998;279:1615-22
    • (1998) JAMA , vol.279 , pp. 1615-1622
    • Downs, J.R.1    Clearfield, M.2    Weis, S.3
  • 10
    • 0037031061 scopus 로고    scopus 로고
    • MRC/ BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial
    • Heart Protection Study Collaborative Group
    • Heart Protection Study Collaborative Group. MRC/ BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22
    • (2002) Lancet , vol.360 , pp. 7-22
  • 11
    • 0035818556 scopus 로고    scopus 로고
    • Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: An idea whose time for testing is coming, part I
    • Shah PK, Kaul S, Nilsson J, Cercek B. Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part I. Circulation 2001;104:2376-83
    • (2001) Circulation , vol.104 , pp. 2376-2383
    • Shah, P.K.1    Kaul, S.2    Nilsson, J.3    Cercek, B.4
  • 12
    • 0029759109 scopus 로고    scopus 로고
    • High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport
    • Assmann G, Schulte H, von Eckardstein A, Huang Y. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 1996;124(Suppl):S11-20
    • (1996) Atherosclerosis , vol.124 , Issue.SUPPL.
    • Assmann, G.1    Schulte, H.2    von Eckardstein, A.3    Huang, Y.4
  • 13
    • 0017384270 scopus 로고
    • High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study
    • Gordon T, Castelli WP, Hjortland MC, et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977;62:707-14
    • (1977) Am J Med , vol.62 , pp. 707-714
    • Gordon, T.1    Castelli, W.P.2    Hjortland, M.C.3
  • 14
    • 0024501678 scopus 로고
    • High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies
    • Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989;79:8-15
    • (1989) Circulation , vol.79 , pp. 8-15
    • Gordon, D.J.1    Probstfield, J.L.2    Garrison, R.J.3
  • 15
    • 34447520136 scopus 로고    scopus 로고
    • Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
    • Bansal S, Buring JE, Rifai N, et al. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007;298:309-16
    • (2007) JAMA , vol.298 , pp. 309-316
    • Bansal, S.1    Buring, J.E.2    Rifai, N.3
  • 16
    • 34447511196 scopus 로고    scopus 로고
    • Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women
    • Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007;298:299-308
    • (2007) JAMA , vol.298 , pp. 299-308
    • Nordestgaard, B.G.1    Benn, M.2    Schnohr, P.3    Tybjaerg-Hansen, A.4
  • 18
    • 29144452513 scopus 로고    scopus 로고
    • High prevalence of low HDL-cholesterol in a pan-European survey of 8545 dyslipidaemic patients
    • Bruckert E, Baccara-Dinet M, McCoy F, Chapman J. High prevalence of low HDL-cholesterol in a pan-European survey of 8545 dyslipidaemic patients. Curr Med Res Opin 2005;21:1927-34
    • (2005) Curr Med Res Opin , vol.21 , pp. 1927-1934
    • Bruckert, E.1    Baccara-Dinet, M.2    McCoy, F.3    Chapman, J.4
  • 19
    • 33748559051 scopus 로고    scopus 로고
    • Prevalence of low HDL-cholesterol in patients with cardiovascular risk factors: The ECHOS (Etude du Cholesterol HDL en Observationnel) French Survey
    • Farmer M, Garnier P, Yau C, et al. Prevalence of low HDL-cholesterol in patients with cardiovascular risk factors: The ECHOS (Etude du Cholesterol HDL en Observationnel) French Survey. Int J Clin Pract 2006;60:1166-71
    • (2006) Int J Clin Pract , vol.60 , pp. 1166-1171
    • Farmer, M.1    Garnier, P.2    Yau, C.3
  • 20
    • 3042695179 scopus 로고    scopus 로고
    • The lipid audit: Analysis of lipid management in two centres in Britain 2003
    • Patel JV, Kirby M, Hughes EA. The lipid audit: analysis of lipid management in two centres in Britain 2003. Br J Cardiol 2004;11:2147
    • (2004) Br J Cardiol , vol.11 , pp. 2147
    • Patel, J.V.1    Kirby, M.2    Hughes, E.A.3
  • 21
    • 4644279733 scopus 로고    scopus 로고
    • Increasing prevalence of the metabolic syndrome among U.S. adults
    • Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 2004;27:2444-9
    • (2004) Diabetes Care , vol.27 , pp. 2444-2449
    • Ford, E.S.1    Giles, W.H.2    Mokdad, A.H.3
  • 22
    • 34247862362 scopus 로고    scopus 로고
    • Blood pressure and estimated risk of stroke in the elderly population of Spain: The PREV-ICTUS study
    • Redon J, Cea-Calvo L, Lozano JV, et al. Blood pressure and estimated risk of stroke in the elderly population of Spain: The PREV-ICTUS study. Stroke 2007;38:1167-73
    • (2007) Stroke , vol.38 , pp. 1167-1173
    • Redon, J.1    Cea-Calvo, L.2    Lozano, J.V.3
  • 23
    • 0042512336 scopus 로고    scopus 로고
    • European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice
    • De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003;24:1601-10
    • (2003) Eur Heart J , vol.24 , pp. 1601-1610
    • De Backer, G.1    Ambrosioni, E.2    Borch-Johnsen, K.3
  • 24
    • 19944363489 scopus 로고    scopus 로고
    • Adaptación Española de la Guia de Prevención Cardiovascular (I). [Spanish adaptation of the European Guide to Cardiovascular Prevention (I)]
    • Brotons C, Royo-Bordonada MA, Alvarez-Sala L, et al. Adaptación Española de la Guia de Prevención Cardiovascular (I). [Spanish adaptation of the European Guide to Cardiovascular Prevention (I)]. Aten Primaria 2004;34:427-32
    • (2004) Aten Primaria , vol.34 , pp. 427-432
    • Brotons, C.1    Royo-Bordonada, M.A.2    Alvarez-Sala, L.3
  • 25
    • 41149155887 scopus 로고    scopus 로고
    • Instituto Nacional de Estadistica de España (Nacional Institute of Statistics of Spain). Cifras de Población. Available at: http://www.ine.es/inebase/cgi/um?M=%2Ft20%2Fe260&O= inebase&N=&L=. [Last accessed: 1 July 2005]
    • Instituto Nacional de Estadistica de España (Nacional Institute of Statistics of Spain). Cifras de Población. Available at: http://www.ine.es/inebase/cgi/um?M=%2Ft20%2Fe260&O= inebase&N=&L=. [Last accessed: 1 July 2005]
  • 26
    • 27444443876 scopus 로고    scopus 로고
    • Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
    • Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-52
    • (2005) Circulation , vol.112 , pp. 2735-2752
    • Grundy, S.M.1    Cleeman, J.I.2    Daniels, S.R.3
  • 27
    • 22044449731 scopus 로고    scopus 로고
    • Components of the metabolic syndrome and risk for first-ever acute ischemic nonembolic stroke in elderly subjects
    • Milionis HJ, Rizos E, Goudevenos J, et al. Components of the metabolic syndrome and risk for first-ever acute ischemic nonembolic stroke in elderly subjects. Stroke 2005;36:1372-6
    • (2005) Stroke , vol.36 , pp. 1372-1376
    • Milionis, H.J.1    Rizos, E.2    Goudevenos, J.3
  • 28
    • 0030974651 scopus 로고    scopus 로고
    • Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study
    • Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study. Arterioscler Thromb Vasc Biol 1997;17:1114-20
    • (1997) Arterioscler Thromb Vasc Biol , vol.17 , pp. 1114-1120
    • Jeppesen, J.1    Hein, H.O.2    Suadicani, P.3    Gyntelberg, F.4
  • 29
    • 0037480160 scopus 로고    scopus 로고
    • High-density vs. low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age
    • Weverling-Rijnsburger AW, Jonkers IJ, van Exel E, et al. High-density vs. low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age. Arch Intern Med 2003;163:1549-54
    • (2003) Arch Intern Med , vol.163 , pp. 1549-1554
    • Weverling-Rijnsburger, A.W.1    Jonkers, I.J.2    van Exel, E.3
  • 30
    • 2542497645 scopus 로고    scopus 로고
    • Effect of atorvastatin on high density lipoprotein cholesterol and its relationship with coronary events: A subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study
    • Athyros VG, Mikhailidis DP, Papageorgiou AA, et al. Effect of atorvastatin on high density lipoprotein cholesterol and its relationship with coronary events: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study. Curr Med Res Opin 2004;20:627-37
    • (2004) Curr Med Res Opin , vol.20 , pp. 627-637
    • Athyros, V.G.1    Mikhailidis, D.P.2    Papageorgiou, A.A.3
  • 31
    • 0032920672 scopus 로고    scopus 로고
    • Influence of baseline lipids on effectiveness of pravastatin in the CARE Trial. Cholesterol And Recurrent Events
    • Pfeffer MA, Sacks FM, Moyé LA, et al. Influence of baseline lipids on effectiveness of pravastatin in the CARE Trial. Cholesterol And Recurrent Events. J Am Coll Cardiol 1999;33:125-30
    • (1999) J Am Coll Cardiol , vol.33 , pp. 125-130
    • Pfeffer, M.A.1    Sacks, F.M.2    Moyé, L.A.3
  • 32
    • 34748887666 scopus 로고    scopus 로고
    • HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events
    • Barter P, Gotto AM, LaRosa JC, et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 2007;357:1301-10
    • (2007) N Engl J Med , vol.357 , pp. 1301-1310
    • Barter, P.1    Gotto, A.M.2    LaRosa, J.C.3
  • 33
    • 0032562257 scopus 로고    scopus 로고
    • Triglyceride concentration and ischemic heart disease: An eight-year follow-up in the Copenhagen Male Study
    • Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation 1998;97:1029-36
    • (1998) Circulation , vol.97 , pp. 1029-1036
    • Jeppesen, J.1    Hein, H.O.2    Suadicani, P.3    Gyntelberg, F.4
  • 34
    • 33846637379 scopus 로고    scopus 로고
    • Triglycerides and the risk of coronary heart disease. 10,158 incident cases among 262,525 participants in 29 western prospective studies
    • Sarwar N, Danesh J, Eiriksdottir G, et al. Triglycerides and the risk of coronary heart disease. 10,158 incident cases among 262,525 participants in 29 western prospective studies. Circulation 2007;115:450-8
    • (2007) Circulation , vol.115 , pp. 450-458
    • Sarwar, N.1    Danesh, J.2    Eiriksdottir, G.3
  • 35
    • 36248963194 scopus 로고    scopus 로고
    • Atorvastatin decreases triacylglycerol-associated risk of vascular events in coronary heart disease patients
    • Athyros VG, Kakafika AI, Papageorgiou AA, et al. Atorvastatin decreases triacylglycerol-associated risk of vascular events in coronary heart disease patients. Lipids 2007;42:999-1009
    • (2007) Lipids , vol.42 , pp. 999-1009
    • Athyros, V.G.1    Kakafika, A.I.2    Papageorgiou, A.A.3
  • 36
    • 25144450879 scopus 로고    scopus 로고
    • Clinical practice. Low HDL cholesterol levels
    • Ashen MD, Blumenthal RS. Clinical practice. Low HDL cholesterol levels. N Engl J Med 2005;353:1252-60
    • (2005) N Engl J Med , vol.353 , pp. 1252-1260
    • Ashen, M.D.1    Blumenthal, R.S.2
  • 37
    • 33646410075 scopus 로고    scopus 로고
    • The effects of statins on high-density lipoproteins
    • Schaefer EJ, Asztalos BF. The effects of statins on high-density lipoproteins. Curr Atheroscler Rep 2006;8:41-9
    • (2006) Curr Atheroscler Rep , vol.8 , pp. 41-49
    • Schaefer, E.J.1    Asztalos, B.F.2
  • 38
    • 2442520797 scopus 로고    scopus 로고
    • Efficacy of extended-release niacin with lovastatin for hypercholesterolemia: Assessing all reasonable doses with innovative surface graph analysis
    • Insull W Jr, McGovern ME, Schrott H, et al. Efficacy of extended-release niacin with lovastatin for hypercholesterolemia: assessing all reasonable doses with innovative surface graph analysis. Arch Intern Med 2004;164:1121-7
    • (2004) Arch Intern Med , vol.164 , pp. 1121-1127
    • Insull Jr, W.1    McGovern, M.E.2    Schrott, H.3
  • 39
    • 0035865542 scopus 로고    scopus 로고
    • Safety and effectiveness of Niaspan when added sequentially to a statin for treatment of dyslipidemia
    • Wolfe ML, Vartanian SF, Ross JL, et al. Safety and effectiveness of Niaspan when added sequentially to a statin for treatment of dyslipidemia. Am J Cardiol 2001;87:476-9
    • (2001) Am J Cardiol , vol.87 , pp. 476-479
    • Wolfe, M.L.1    Vartanian, S.F.2    Ross, J.L.3
  • 40
    • 34547205154 scopus 로고    scopus 로고
    • Safety and tolerability of prolonged-release nicotinic acid in statin-treated patients
    • Birjmohun RS, Kastelein JJ, Poldermans D, et al. Safety and tolerability of prolonged-release nicotinic acid in statin-treated patients. Curr Med Res Opin 2007;23:1707-13
    • (2007) Curr Med Res Opin , vol.23 , pp. 1707-1713
    • Birjmohun, R.S.1    Kastelein, J.J.2    Poldermans, D.3
  • 41
    • 10044281651 scopus 로고    scopus 로고
    • Arterial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER) 2: A double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins
    • Taylor AJ, Sullenberger LE, Lee HJ, et al. Arterial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins. Circulation 2004;110:3512-17
    • (2004) Circulation , vol.110 , pp. 3512-3517
    • Taylor, A.J.1    Sullenberger, L.E.2    Lee, H.J.3
  • 42
    • 30144445801 scopus 로고    scopus 로고
    • Prolonged-release nicotinic acid: A review of its use in the treatment of dyslipidaemia
    • McCormack PL, Keating GM. Prolonged-release nicotinic acid: a review of its use in the treatment of dyslipidaemia. Drugs 2005;65:2719-40
    • (2005) Drugs , vol.65 , pp. 2719-2740
    • McCormack, P.L.1    Keating, G.M.2
  • 43
    • 34249024864 scopus 로고    scopus 로고
    • Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1
    • Lai E, De Lepeleire I, Crumley TM, et al. Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1. Clin Pharmacol Ther 2007;81:849-57
    • (2007) Clin Pharmacol Ther , vol.81 , pp. 849-857
    • Lai, E.1    De Lepeleire, I.2    Crumley, T.M.3
  • 44
    • 4344665253 scopus 로고    scopus 로고
    • Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: The role of nicotinic acid - a position paper developed by the European Consensus Panel on HDL-C
    • Chapman MJ, Assmann G, Fruchart JC, et al. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid - a position paper developed by the European Consensus Panel on HDL-C. Curr Med Res Opin 2004;20:1253-68
    • (2004) Curr Med Res Opin , vol.20 , pp. 1253-1268
    • Chapman, M.J.1    Assmann, G.2    Fruchart, J.C.3
  • 45
    • 41149123132 scopus 로고    scopus 로고
    • Treatment of HDL to reduce the incidence of vascular events HPS2-THRIVE. Clinicaltrials.gov, NCT00461630. Available at: http://www.clinicaltrials.gov/ct/ show/NCT00461630?order=1 [Last accessed: 24 September 2007]
    • Treatment of HDL to reduce the incidence of vascular events HPS2-THRIVE. Clinicaltrials.gov, NCT00461630. Available at: http://www.clinicaltrials.gov/ct/ show/NCT00461630?order=1 [Last accessed: 24 September 2007]
  • 46
    • 35848945939 scopus 로고    scopus 로고
    • Effects of statins on renal function
    • Agarwal R. Effects of statins on renal function. Mayo Clin Proc 2007;82:13
    • (2007) Mayo Clin Proc , vol.82 , pp. 13
    • Agarwal, R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.